Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Argus Health
Baxter
Medtronic
Accenture
Harvard Business School

Generated: June 25, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019722

Try a free trialSee Plans and Pricing

« Back to Dashboard

NDA 019722 describes NASCOBAL, which is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from two suppliers. There are six patents protecting this drug and one Paragraph IV challenge. Additional details are available on the NASCOBAL profile page.

The generic ingredient in NASCOBAL is cyanocobalamin. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
Summary for 019722
Tradename:NASCOBAL
Applicant:Par Pharm
Ingredient:cyanocobalamin
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:GEL, METERED;NASALStrength0.5MG/INH
Approval Date:Nov 5, 1996TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Fuji
Covington
Teva
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.